Drug
Intraosseous Vancomycin
Intraosseous Vancomycin is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
recruiting133%
not_yet_recruiting267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial
NCT07338773
not_yet_recruitingnot_applicable
IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA
NCT07283068
not_yet_recruitingphase_2
IO Vancomycin Spine
NCT06748144
Clinical Trials (3)
Showing 3 of 3 trials
NCT07338773Phase 4
Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial
NCT07283068Not Applicable
IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA
NCT06748144Phase 2
IO Vancomycin Spine
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3